Skip to main content
logo
Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0129
-0.0037 (-22.29%)
At close: Nov 5, 2026

Oncotelic Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
63714151863
Market Cap Growth
-87.20%160.46%-6.64%-13.25%-71.94%225.64%
Enterprise Value
185026272770
Last Close Price
0.010.080.040.040.040.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.020.15--3.45-
PS Ratio
23.61--218.13--
PB Ratio
0.020.141.911.320.927.69
P/TBV Ratio
0.020.142.612.492.40-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
73.96--384.58--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.051.751.080.591.10
Net Debt / Equity Ratio
0.050.051.741.070.571.03
Net Debt / EBITDA Ratio
----22.47-1.97-0.93
Asset Turnover
0.00--0.00--
Quick Ratio
0.010.010.010.010.020.04
Current Ratio
0.080.070.010.020.020.04
Return on Equity (ROE)
182.61%185.00%-50.08%-53.28%34.20%-101.92%
Return on Assets (ROA)
-1.64%-0.89%-0.83%-1.07%-11.74%-24.13%
Return on Invested Capital (ROIC)
-1.37%-1.39%-1.69%-2.08%-23.98%-54.90%
Return on Capital Employed (ROCE)
-1.50%-0.80%-5.00%-4.20%-29.20%-111.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
4361.23%671.40%-31.74%-51.76%28.95%-14.97%
Buyback Yield / Dilution
-7.93%-4.12%-5.29%16.01%-50.89%-244.02%